Zantac, a popular over-the-counter, generic and prescription medication used to treat heartburn, was recalled by its manufacturer, Sanofi, in October 2019. The U.S. Food and Drug Administration (FDA) had found trace amounts of an impurity in the medication linked to the development of several forms of cancer. The medication, also known as Ranitidine, was tested and the results showed the presence of a chemical called N-Nitrosodimethylamine (NDMA). Unfortunately, the chemical found its way into the manufacturing process of several varieties of Zantac, as well as generic versions of Ranitidine.
The FDA labels NDMA an “environmental contaminant” and “probably [a] human carcinogen.” Since the FDA’s discovery, manufacturers, distributors and retailers have recalled and pulled all Zantac and Ranitidine products off the shelves. In response, Evan M. Ostfeld, P.A. is currently accepting Zantac and Ranitidine cancer cases. People need representation, and we are here to help. If you have Zantac and Ranitidine products in your home, stop using them immediately!
Don’t, however, discard the boxes or bottles as they may be needed to show proof of use. Those who took Zantac or generic Ranitidine for at least one year may be at higher risk for developing the following cancers:
If you or a loved one have taken Zantac/Ranitidine and developed cancer, or your loved one passed away after using it, call us. We guide our clients throughout the entire process and keep them apprised of any case developments.
Contact us today at (866) BAD RXRX, (866) I SUE YOU, (954) 227-7529; text (954) 998-0075 or email at email@example.com for a no obligation case evaluation.
Mind you that there are no attorney’s fees or costs unless there is a settlement or court award. You have nothing to lose for us to investigate the case; we’ll even pay to obtain your medical records!